Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Armodafinil, Bupropion, and Minocycline for Chemoradiation Symptoms in Head and Neck Cancer
NCT01219673Phase 2Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Mar 2013
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of armodafinil, bupropion, minocycline in adverse effects of chemotherapy and radiotherapy, sponsored by University of Texas MD Anderson Cancer Center. Started Mar 2013; status: terminated.
02
Drugs
armodafinilbupropionminocycline
03
Conditions
adverse effects of chemotherapy and radiotherapy
Beyond the preview
Go deeper on NCT01219673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01219673.